Cytochrome P-450 and drug development for skin diseases

Skin Pharmacology and Physiology

Volumn 9, Issue 4, 1996, Pages 231-241

  Ahmad, Nihal ^a   Agarwal, Rajesh ^a   Mukhtar, Hasan ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytochrome P 450; Drug metabolism

Indexed keywords

ANTIHISTAMINIC AGENT; CHLOROQUINE; CLOTRIMAZOLE; CYCLOSPORIN; CYTOCHROME P450; DAPSONE; DEXAMETHASONE; GLUCOCORTICOID; GRISEOFULVIN; HYDROXYCHLOROQUINE; IMIDAZOLE DERIVATIVE; ITRACONAZOLE; KETOCONAZOLE; LIAROZOLE; MICONAZOLE; PSORALEN DERIVATIVE; RETINOIC ACID; RIFAMPICIN; STEROID; VITAMIN D;

DRUG BIOAVAILABILITY; DRUG METABOLISM; MAMMAL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKIN DISEASE;

ARYL HYDROCARBON HYDROXYLASES; HUMANS; PHARMACEUTICAL PREPARATIONS; SKIN DISEASES; TRETINOIN;

EID: 0029736980     PISSN: 16605527     EISSN: 16605535     Source Type: Journal    
DOI: 10.1159/000211420     Document Type: Article

References (67)

1. Rice RH, Cohen DE: Toxic response of skin; in Klassen CD (ed): Toxicology: The Basic Science of Poison. New York. McGraw-Hill. 1996. pp 529-546.
2. Gonzales FJ: The molecular biology of cytochrome P-450s. Pharmacol Rev, 1989:40:243-288.
3. Nebert DW, Feyereisen R: Evolutionary argument for a connection between drug metabolism and signal transduction; in Levhner MC (ed): Proceedings of the 8th International Conference Cytochrome P-450: Biochemistry. Biophysics and Molecular Biology. Paris. Eurotex. 1994, pp 3-13.
4. Garfinkel D: Studies on pig liver mi-crosomes. I. Enzymatic and pigment composition of different microsomal preparations. Arch Biochem Bio-phvs 1985;77:376-381.
5. Klingenberg M:Pigmentsof rat liver microsomes. Arch Biochem Biophys 1958;75:376-380.
6. Gucngcrich FP: Cytochrome P450: Advances and prospects. FASEB J 1992;6:667-675.
7. Conney AH: Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons. Cancer Res 1982;42:4875-4917.
8. Mukhtar H, Khan WA: Cutaneous cytochrome P450. Drug Metab Rev 1989;20:657-673.
9. Mukhtar H, Agarwal R, Bickers DR: Cutaneous metabolism, of xenobio-lics and steroid hormones; in Mukhtar H (ed): Pharmacology of the Skin. Boca Raton. CRC Press, 1991. pp 89-109.
10. Conney AH, Miller EC, Miller JA: The methylated aminoazodyes. V. Evidence for induction of enzyme synthesis in rats by 3-methylcholan-threnc. Cancer Res 1956; 16:450-459.
11. Conney AH, Miller EC, Miller JA: Substrate induced synthesis and other properties of benzpyrene hydroxylase in rat liver. J Biol Chem 1957;228:753-776.
12. Mukhtar H, Bickers DR: Age related changes in bcnzo(a)pyrene metabolism and epoxide metabolizing enzyme activities in rat skin. Drug Metab Dispos 1983,11:562-567.
13. Merk FIF, Mukhtar H, Kaufman I, Das M, Bickers DR: Human hair follicle benzo(a)pyrene and benzo-(a)pyrene 7,8-diol metabolism: Effect of exposure to a coal tar containing shampoo. J Invest Dermatol 1987;88:71-76.
14. Whitlock JP Jr: The regulation of cytochrome P450 gene expression. Annu Rev Pharmacol Toxicol 1987; 26:333-369.
15. Finnen MJ, Herdman ME, Shuster S: Induction of drug metabolizing enzymes in the skin by topical steroids. J Steroid Biochem 1984;20: 1169-1173.
16. Khan IU, Bickers DR, Haqqi TM, Mukhtar H: Induction of CYP1A1 mRNA in rat epidermis and cultured human epidermal keratino-cytes by bcnz(a)anthraccnc and P-naphthoflavone. Drug Metab Dispos 1992;22:620-624.
17. Raza H, Agarwal R, Bickers DR, Mukhtar R: Purification and molecular characterization of ß-naphtho-llavonc inducible cytochrome P-450 from rat epidermis. J invest Dermatol 1992:98:233-240.
18. Stäuber KL, Laskin JD, Yurkow EJ, Thomas PE, Laskin DL, Conney AH: Flow cytometry reveals subpopulations of murine epidermal cells that are refractory to induction of cytochrome P-450 1A1 by ß-naphthoflavone. J Pharmacol Exp Ther 1995:273:967-976.
19. Reiners JJ, Cantu AR Jr, Thai G, Scholler A: Differential expression of basal and hydrocarbon induced cytochrome P-450 monooxygenase and quinone reductase activities in subpopuiations of murine epidermal cells differing in their stages of differentiation. Drug Metab Dispos 1992:20:360-366.
20. Gonzalez FJ: Role of cytochrome P450 1A1 in skin cancer; in Mukhtar H (ed): Skin C'anccr: Mechanism and Human Relevance. Boca Raton. CRC Press. 1995. pp 89-97.
21. Pham MA, Magdalou J, Totis M, Foumel-Ginleux S. Siest G. Hammock BD: Characterization of distinct forms of cytochrome P-450, epoxide metabolizing enzymes and U DP-glucu ronosvll ransferascs in rat skin. Biochem Pharmacol 1989; 38:2187-2194.
22. Lilienblum W. Irmscher G. Fusenig N, Bock K: Induction of UDP-glu-curonosyltransfcrases in rat skin. Biochem Pharmacol 1985:35:1517-1520.
23. Wattenberg LW, Leong JL: Histo-chemical studies of polycyclic hydrocarbon metabolizing systems. J Histochem Soc 1962:10:659.
24. Raza H, Mukhtar H: Differences in inducibility of cytochrome P-450 1AI, monooxygcnascs and gluta-thione-S-transferases in cutaneous and extra-cutaneous tissues after topical and parenteral administration of ß-naphlhoflavone to rats. Int J Biochem 1993:10:1511-1516.
25. Khan WA, Park SS, Gelboin HV, Bickers DR, Mukhtar H: Epidermal cytochrome P-450: Immunochemical characterization of isoform induced by topical application of 3-methylcholanthrcnc to neonatal rats. J Pharmacol Exp Ther 1989: 249:921-924.
26. Schiede E, Conney AH: Induction of benzo(a)pyrenc hydroxylase activity in rat skin. Life Sei 1970:9:1295-1303.
27. Levin W, Conney AH, Alvares AP, Merkatz I, Kappas A: Induction of benzo(a)pyrenc hydroxylase in human skin. Science 1972:176:419-420.
28. Alvares AP, Kappas A, Levin W, Conney AH: Inducibility of bcn-zo(a)pyrene hydroxylase in human skin by polycyclic hydrocarbons. Clin Pharmacol Ther 1973:14:30-40.
29. Bickers DR, Kappas A, Alvares AP: Differences in inducibility of cutaneous and hepatic drug metabolizing enzymes and cytochrome P-450 by polychlorinated biphenyls and 1.1.1 -trichloro-2.2.-bis(p-chlorophe-nyl)ethane(DDT). J Pharmacol Exp Ther 1974:188:300-309.
30. Bickers DR, Eiscman J, Kappas A, Alvares AP: Microscope immersion oils: Effects of skin application on cutaneous and hepatic drug metabolizing enzymes. Biochem Pharmacol 1975:24:779-783.
31. Thompson S, Slaga TJ: Mouse epidermal aryl hydrocarbon hydroxylase. J Invest Dermatol 1976:66: 108-111.
32. Weibel FJ, Leutz JC, Diamond L, Gelboin HV: Aryl hydrocarbon (bcnzo(a)pyrene) hydroxylase in mi-crosomcs from rat tissue: Differential inhibition and stimulation by benzoflavoncs and organic solvents. Arch Biochem Biophys 1971:144:78-86.
33. Weibel FJ, Leutz JC, Gelboin HV: Aryl hydrocarbon (benzo(a)pyrenc) hydroxylase: A mixed function oxygenase in mouse skin. J Invest Dermatol 1975;64:184-189.
34. Briggs MM, Briggs M: Induction by topical corticosteroids of skin enzymes metabolizing carcinogenic hydrocarbons. Br J Dermatol 1973; 88:75-81.
35. Mukhtar H, Bickers DR: Comparative activity of the mixed function oxidases, epoxide hydratase. and glutathione-S-transferase in liver and skin of the neonatal rat. Drug Metab Dispos 1981;9:311-314.
36. Bickers DR, Wroblewski D, Dutla-Choudhury T, Mukhtar H: Induction of neonatal rat skin and liver hydrocarbon hydroxylase by coal tar and its constituents. J Invest Dermatol 1982;78:227-229.
37. Mukhtar H, Bickers DR: Evidence that coal tar is a mixed inducer of microsomal drug metabolizing enzymes. Toxicol Lett 1982:11:221-227.
38. Mukhtar H, Link CM, Chcmiack E, Kushiner DM, Bickers DR: Effect of topical application of defined constituents of coal tar on skin and liver aryl hydrocarbon hydroxylase and 7-ethoxycoumarin decthvlase activities. Toxicol Appl Pharmacol 1982: 64:541-549.
39. Merk HF, Khan WA, Khun C, Bickers DR, Mukhtar H: Effect of topical application of clotrimazole to rats on epidermal and hepatic monooxy-gcnasc activities and cytochrome P-450. Arch Dermatol Res 1989:281: 198-202.
40. Jugcrt FK, Agarwal R, Khun A, Bickers DR, Merk HF, Mukhtar H: Multiple cytochrome P-450 isozymes in murine skin: Induction of P450 1AI. 2B. 2E and 3A by dcxa-methasone. J Invest Dermatol 1994; 102:970-975.
41. Agarwal R, Jugert FK, Khan SG, Bickers DR, Merk HF, Mukhtar H: Evidence for multiple inducible cytochrome P450 isozyme in Senear mouse skin by pyridine. Biochem Biophys Res Commun 1994:199: 1400-1406.
42. Sutler TR, Tang YM. Haycs CL, Wo YYP, Jabs EW, Li X, Yin H, Cody CW, Greenlee WF: Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J Biol Chem 1994:269:13092-13099.
43. Shapiro S: Retinoids and epithelial differentiation; in Sherman M (ed): Retinoids and Cell Differentiation. Boca Raton, C’RC Press. 1986. pp 5-59.
44. Roberts AB, Lamb LC, Sporn MB: Metabolism of all-trans-retinoic acid in hamster liver microsomcs: Oxidation of 4-hydroxy-4-ketorcti-noic acid. Arch Biochem Biophys 1980;199:557-564.
45. Williams JB, Napoli JL: Inhibition of retinoic acid metabolism by imidazole anti-mycotics in F9 embryonal carcinoma cell. Biochem Pharmacol 1987;36:1386-1388.
46. Williams JB, Napoli JL: Metabolism of retinoic acid and retinol during differentiation of F9 embryonal cell. Proc Natl Acad Sei USA 1985; 82:4658-4662.
47. Martini R, Murray M: Participation of P450 3A in rat hepatic microsomal retinoic acid 4-hydroxylation. Arch Biochem Biophys 1993:303: 55-66.
48. Roberts E, Vaz A, Coon MJ: Role of isozymes of rabbit microsomal cytochrome P450 in metabolism of retinoic acid, retinol and retinal. Mol Pharmacol 1991:41:427-433.
49. Li XY, Astrom A, Duell EA, Qin L, Griffiths CEM, Voorhees JJ: Retinoic acid antagonizes basal as well as coal tar and glucocorticoid-in-duccd cytochrome P450 1A1 expression in human skin. Carcinogenesis 1995:16:519-524.
50. VanWauwe JP, Janssen PAJ: Is there a place for P450 inhibitors in cancer treatment? J Med Chem 1989:32:2231-2239.
51. Dockx P, Decree J, Degreef H: Inhibition of endogenous retinoic acid as treatment for severe psoriasis: An open study with oral liarozolc. Br J Dermatol 1995:133:426-432.
52. Cauwenbergh G: New and prospective developments in antifungal drugs. Acta Derm Vencrcol 1986; 121:147-153.
53. Veechini F, Michel S: Importance of cytochrome P450 for the development of new drug concepts in the skin. Eur J Dermatol 1994:4:583-588.
54. Vanden Bossche H, Willemsen G: Retinoic acid and cytochrome P450; in Saurat JH (ed): Retinoids: 10 years on. Basel. Karger. 1991. pp 79-88.
55. 4 in rodent and human epidermis. J Invest Dermatol 1989; 93:231-235.
56. Holtzman MJ, Turk J, Pentland A: A rcgion-spccific monooxvgenase with novel stcreopreference is the major pathway for arachidonic acid oxygenation in isolated epidermal cells. J Clin Invest 1989:84:1446-1453.
57. Voorhees JJ: Lcukotriencs and other lipooxygenase products in the pathogenesis and therapy of psoriasis and other dermatoses. Arch Dermatol 1983;119:541-547.
58. Farr PM, Drause LB, Marks JM, Shuster S: Response of scalp psoriasis to oral ketoconazole. Lancet 1985;ii:921-922.
59. Rottein DM, Kertesz DJ, Walker KAM, Swinney DC: Stereoisomers of ketoconazole preparation and biological activity. J Med Client 1992;35:2818-2825.
60. Ghetti P, Patrone P, Tosti A: Keto-conazolc in the treatment of acne in women. Arch Dermatol 1986:122: 629-634.
61. Carvalho D, Pignatelli D, Resende C: Kctoconazole for hirsutism. Lancet 1985;ii:560.
62. Darmon M: Retinoic acid in skin and epithelia. Dev Biol 1991;2:219-228.
63. Das M, Khan VA, Asokan P, Bickers DR, Mukhtar H: Inhibition of polycyclic aromatic hvdrocarbon-DNA adduct formation in epidermis and lungs of Senear mice by naturally occurring plant phenols. Cancer Res 1987;47:767-773.
64. DeCoster R, Caers I, Coenc MC, Amery W, Beerens D, Haclterman C: Effects of high dose kctoconazole therapy on the main plasma testicular and adrenal steroids in previously untreated prostatic cancer patients. Clin Endocrinol 1986:24: 657-664.
65. Das M, Mukhtar H, Del Tito BJ, Marcelo CL, Bickers DR: Clotrimazole. an inhibitor of benzo(a)pyrene metabolism and its subsequent glu-curonidation. sulfation, and macro-molecular binding in BALB/C mouse cultured keratinocytes. J Invest Dermatol 1986;87:4-10.
66. Mukhtar H, Del Tito BJ, Das M, Chemiack EP, Cherniack AD, Bickers DR: Clotrimazole, an inhibitor of epidermal bcnzo(a)pyrene metabolism and DNA binding and carcin-ogeneity of the hydrocarbon. Cancer Res 1984:44:4233-4240.
67. Coon MJ, Vaz AND, Bestervell LL: Peroxidative reactions of diverso-zymcs. FASEBJ 1996:10:428-434.